DCHCARE | DC HEALTHCARE HOLDINGS BERHAD
0.120 (4.35%)
T-O (am): 0.115 (08:59:00)
Last updated: 16:59
DCHCARE Fundamental Trend
FCON: | Sharpe Ratio: | LTS:
DCHCARE Quarter Reports
Customize
Select columns required and click "Update" to save your preferences
| Ann. Date | Qtr. Date | Q | FYE | Revenue [M] | PBT [M] | NP [M] | NPM | DPS | EPS | R. QoQ | R. YoY | E. QoQ | E. YoY | TTM EPS |
Adj. [M] |
NP [M] (adj) |
NPM (adj) |
EPS (adj) |
E. QoQ (adj) |
E. YoY (adj) |
TTM EPS (adj) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25 Nov 25 | Q3 Sep 25 | 3 | 31 Dec 25 | 25.72 | 3.06 | 2.30 | 8.9% | 0.00 | 0.23 | 24.9% | 62.7% | 322.5% | 206.7% | ||||||||
| 26 Aug 25 | Q2 Jun 25 | 2 | 31 Dec 25 | 20.60 | -1.03 | -1.03 | -5.0% | 0.00 | -0.10 | 15.1% | 48.4% | 23.1% | 84.6% | ||||||||
| 21 May 25 | Q1 Mar 25 | 1 | 31 Dec 25 | 17.90 | -0.84 | -0.84 | -4.7% | 0.00 | -0.08 | 7.8% | 89.4% | 71.8% | 89.4% | ||||||||
| 25 Feb 25 | Q4 Dec 24 | 4 | 31 Dec 24 | 16.61 | -3.24 | -2.97 | -17.9% | 0.00 | -0.30 | 5.1% | 5.5% | 38.1% | 177.2% | ||||||||
| 26 Nov 24 | Q3 Sep 24 | 3 | 31 Dec 24 | 15.81 | -2.15 | -2.15 | -13.6% | 0.00 | -0.22 | 13.9% | 1.9% | 67.9% | 21.4% | ||||||||
| 27 Aug 24 | Q2 Jun 24 | 2 | 31 Dec 24 | 13.88 | -6.71 | -6.71 | -48.4% | 0.00 | -0.67 | 46.8% | 22.4% | 15.2% | 267.1% | ||||||||
| 27 May 24 | Q1 Mar 24 | 1 | 31 Dec 24 | 9.45 | -7.91 | -7.91 | -83.7% | 0.00 | -0.79 | 46.2% | 43.8% | 637.1% | 435.6% | ||||||||
| 27 Feb 24 | Q4 Dec 23 | 4 | 31 Dec 23 | 17.57 | -0.27 | -1.07 | -6.1% | 0.00 | -0.11 | 13.3% | 60.9% | ||||||||||
| 30 Nov 23 | Q3 Sep 23 | 3 | 31 Dec 23 | 15.51 | -3.13 | -2.74 | -17.7% | 0.00 | -0.28 | 13.3% | 168.2% | ||||||||||
| 29 Aug 23 | Q2 Jun 23 | 2 | 31 Dec 23 | 17.89 | 5.27 | 4.02 | 22.4% | 0.00 | 0.50 | 6.4% | 70.4% | ||||||||||
| 11 Jul 23 | Q1 Mar 23 | 1 | 31 Dec 23 | 16.81 | 3.19 | 2.36 | 14.0% | 0.00 | 0.30 |
DCHCARE Historical Dividends
DCHCARE Financial Ratios
| EPS | -0.26 sen |
| Trailing PE (Sector Median: 27.8) | 0.0 |
| PEG | 0.0 |
| Altman Z | 0.7 |
| Beaver | 0.16 |
| Current Ratio | 1.12 |
| Debt-Equity (DE) Ratio | 1.29 |
| FCF Yield | 3.65 % |
| Revenue QoQ | 24.89 % |
| Revenue YoY | 62.72% |
| Profit QoQ | 322.46 % |
| Profit YoY | 206.73 % |
| Profit Margin (Sector Median: 7.5) | -3.15 % |
| ROE (ROIC: -5.4) | -5.64 % |
| Dividend Per Share (DPS) | 0.0 sen |
| Dividend Yield (DY) | 0.0 % |
DCHCARE Adjusted Financial Ratios
Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports
| EPS | |
| Trailing PE (Sector Median: 27.8) | |
| Profit QoQ | |
| Profit YoY | |
| Profit Margin (Sector Median: 7.5) | |
| ROE (ROIC: -1.13) | |
| Altman Z |
DCHCARE Fair Value
Weighted Average Fair Value:
| Discounted Cash Flow (DCF) 5% Growth | |
| Discounted Cash Flow (DCF) 10% Growth | |
| Relative Valuation |
| Graham Formula | |
| Graham Number | |
| Net Tangible Asset (NTA) | 0.05 | Consistent QR FV |
Advanced Calculators
Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.
| Forward PE FV Calculator | |
| Latest Profit (adjusted) [M] | 2.97 |
| Expected Profit (Next QR) [M] | |
| Expected Profit (After QR above) [M] | |
| Expected Profit (After QR above) [M] | |
| Estimated Fair Value |
| Growth/Risk Fair Value Calculator | |
| Expected growth (%) | |
| Estimated downside / risk (%) | |
| Estimated New DCF Fair Value |
| Contract/Award Contribution Calculator | |
| Contract/Award Value (in Million) | |
| Estimated Contribution to Stock Price | |
| Estimated New DCF Fair Value |
| Profit-Based Calculator | |
| Expected Profit (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Revenue-Based Calculator | |
| Expected Revenue (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Market Pricing | |
| Expected Profit (M) | 0 |
| Expected Revenue (M) | 0 |
| Expected Growth (%) | 0 |
DCHCARE Directors Share Purchases (Beta)
DR LAI NGAN CHEE added 117100.0 units announced on 22 Jan 2024 at ~RM0.33
DR CHONG TZE SHENG added 117100.0 units announced on 22 Jan 2024 at ~RM0.33
DR CHONG TZE SHENG added 200000.0 units announced on 22 Sep 2023 at ~RM0.455
DR LAI NGAN CHEE added 200000.0 units announced on 22 Sep 2023 at ~RM0.455
MISS SIM LEE SAN reduced 100000.0 units announced on 26 Jul 2023 at ~RM0.445
MISS SIM LEE SAN reduced 100000.0 units announced on 20 Jul 2023 at ~RM0.44
MISS REKHA A/P PALANYSAMY reduced 200000.0 units announced on 18 Jul 2023 at ~RM0.4
MISS YAP EE LING reduced 210000.0 units announced on 18 Jul 2023 at ~RM0.4
DCHCARE Summary
Market Cap: 119 M.
Market Cap Class: Micro caps
Number of Shares: 996 M.
Adjusted Float: 0%.
Stock highly correlated with
ZHULIAN (97%)
ARTRONIQ (95%)
INNATURE (95%)
PWROOT (95%)
DC Healthcare Holdings Berhad is principally an investment holding company. Through its subsidiaries, the company provides aesthetic medical services, specializing in non-invasive and minimally invasive procedures. It operates in two segments namely aesthetic services and general medical services. The aesthetic services include facial and skin treatments, facial sculpting, body contouring, hair growth and removal and the sale of skincare products. Meanwhile, the general medical services focus on skin disease treatment and blood test screening services. The company manages 13 aesthetic medical clinics located in the Central Region and Southern Region. DC Healthcare was incorporated in 2022 and is headquartered in Kuala Lumpur, Malaysia.
Sectors: Healthcare, Health Care Providers, Penny Stocks
Code: 0283
Website: https://www.dchealthcareholdings.com/
Related Links: Bursa | Annual Report | Announcement
Warrant Info:
No warrants listed
DCHCARE Top Shareholdings
| Shareholder | % | Value (M) |
|---|---|---|
| Dr Chong Tze Sheng | 4.87% | 5.82 |
| Dr Lai Ngan Chee | 2.95% | 3.53 |
| Datuk Dr Mohd Noor Bin Awang | 0.0% | 0.0 |
Frequently Asked Questions
DC HEALTHCARE HOLDINGS BERHAD Latest News
DCHCARE Insights+
Some features of iSaham Insights are exclusively available to iSaham Pro clients.
Learn More about iSaham ProResearch House Target Price
Average Target Price: N/A
Entitlements
(Bonus Issue, Share Split or Share consolidation for the past 3 years)
| Ex-Date | Category | Entitlements |
|---|---|---|
| No entitlements detected |
Private Placements
(Fund raising via private placement shares for the past 3 years)
| Date | Stage | Purpose | Issue Price |
|---|---|---|---|
| No Private Placements detected |